Effect of Domperidone on Completion Rate of Vedio Capsule Endoscopy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03662113|
Recruitment Status : Completed
First Posted : September 7, 2018
Last Update Posted : December 17, 2018
|Condition or disease||Intervention/treatment||Phase|
|Capsule Endoscopy Pediatric Disorder||Drug: Domperidone Dietary Supplement: water||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||200 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Investigator, Outcomes Assessor)|
|Primary Purpose:||Health Services Research|
|Official Title:||Effect of Domperidone on Completion Rate of Vedio Capsule Endoscopy: a Prospective Randomized Controlled Study|
|Actual Study Start Date :||November 1, 2017|
|Actual Primary Completion Date :||November 1, 2018|
|Actual Study Completion Date :||November 1, 2018|
Experimental: Experimental: Domperidone
5ml domperidone prior to VCE
5ml Domperidone prior to VCE
Other Name: simethicone
5ml warm water prior to VCE
Dietary Supplement: water
5ml water prior to VCE
Other Name: simethicone
- Completion rate of capsule endoscopy [ Time Frame: assessed through study completion, an average of 1 year ]CE was considered complete when the cecum was reached within recording time.
- Gastric transit time (GTT) [ Time Frame: assessed through study completion, an average of 1 year ]The GTT was defined as the time, in minutes, from the first image of the stomach until the first image of the duodenum.
- small bowel transit time (SBTT) [ Time Frame: assessed through study completion, an average of 1 year ]The SBTT was defined as the passage time, in minutes, from the first image of the duodenum until the first image of the cecum.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03662113
|Children's hospital of Fudan university|
|Shanghai, Shanghai, China, 201102|
|Study Director:||Ying Huang, doctor||Children's Hospital of Fudan University|